Boxlight regained compliance with Nasdaq’s $2,500,000 Equity requirement after a PIPE generated approximately $6.6 million net. Nasdaq granted continued listing, but a monitoring period removes certain cure opportunities if another listing-rule breach occurs, potentially putting Boxlight’s securities at risk of delisting.
Key Highlights
- The Nasdaq Hearings Panel determined that Boxlight regained compliance with the $2.5 million stockholders’ equity requirement.
- The Panel granted Boxlight’s request for continued listing on Nasdaq.
- Boxlight closed Tranche One of its Series D financing on August 5, raising $4.8 million net of fees.
Boxlight Corp (NASDAQ: BOXL) regained compliance with Nasdaq’s equity requirement, which calls for at least $2,500,000 in stockholders’ equity. Nasdaq also granted the company continued listing after a plan that included approximately $6.6 million in net PIPE proceeds.
Financing Plan Supports Continued Listing
Boxlight received the Nasdaq Hearings Panel’s decision on September 2, following a hearing on August 13 where Boxlight presented the plan.
Nasdaq Monitor Limits Future Cure Options
A Discretionary Panel Monitor took effect on August 17. Boxlight could then request a new hearing, while its securities could be Delisted from Nasdaq.
FAQs
Q: Why did Boxlight regain Nasdaq compliance?
A: The Nasdaq Hearings Panel determined that Boxlight had regained compliance with Nasdaq’s $2,500,000 stockholders’ equity requirement. The company presented a compliance plan at a hearing held on August 13.
Q: What financing did Boxlight complete?
A: Boxlight closed Tranche One of its Series D Convertible Preferred Stock Financing on August 5, 2026. The tranche raised $4.8 million, net of fees.
Q: What happens if Boxlight is found out of compliance during the monitoring period?
A: Nasdaq staff would issue a delisting determination letter instead of allowing Boxlight to provide a compliance plan or receive additional time to regain compliance. Boxlight could request a new hearing, and its securities may be delisted from Nasdaq.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.